Search Within

Andrew D Seidman

  1. "2000"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (3)
Groups
  1. Breast Medicine Service (8)
  2. Department of Medicine (8)
  3. Solid Tumor Oncology Division (8)
  4. Survivorship Research (6)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  6. Department of Pathology and Laboratory Medicine (3)

More Groups

People
  1. Larry Norton (5)
  2. Clifford Hudis (4)
  3. Crispinita Arroyo (3)
  4. Lee Tan (3)
  5. Monica Fornier (3)
  6. Stamatina Kaptain Sakellakis (2)

More People

Years
  1. 2000 (8)
Publications
  1. Clinical Breast Cancer (2)
  2. Breast Cancer Research and Treatment (1)
  3. Cancer Chemotherapy and Pharmacology (1)
  4. European Journal of Cancer (1)
  5. Journal of Clinical Oncology (1)
  6. Laboratory Investigation (1)

More Publications

Publishers
  1. Elsevier Inc. (4)
  2. Springer (2)
  3. American Society of Clinical Oncology (1)
  4. Nature Publishing Group (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) for Her2/neu in metastatic breast cancer (BC)
    Meeting Abstract

    Kaptain, S.; Seidman, A. D.; Esteva, F. J.; Fornier, M.; Arroyo, C.; Chin, J.; Willey, J.; Reuter, V.; Hudis, C.; Norton, L.; more...
    Laboratory Investigation (2000)

    Fulltext@MSK | Save
  • Weekly (W) herceptin (H) and taxol (T) for metastatic breast cancer (MBC): Correlation of response rate to HER2 immunophenotype (immunohistochemistry (IHC)) and gene amplification (fluorescent in-situ hybridization (FISH))
    Meeting Abstract

    Fornier, M.; Seidman, A. D.; Esteva, F.; Tan, L.; Kaptain, S.; Bach, A.; Arroyo, C. D.; Hortobagyi, G.; Norton, L.; Hudis, C.
    European Journal of Cancer (2000)

    Fulltext@MSK | Save
  • Clinical-pathologic assessment of the clinical sensitivity to single agent taxane (T) therapy for metastatic breast cancer (MBC)
    Meeting Abstract

    Van Poznak, C.; Tan, L.; Panageas, K.; Arroyo, C.; Hudis, C.; Norton, L.; Seidman, A. D.
    Breast Cancer Research and Treatment (2000)

    Fulltext@MSK | Save
  • Commentary on 'Paclitaxel, 5-fluorouracil, and leucovorin (TFL) in the treatment of metastatic breast cancer'
    Journal Article

    Seidman, A.
    Clinical Breast Cancer (2000)

    Fulltext@MSK | Save
  • Commentary on 'High-dose chemotherapy with hematopoietic stem-cell transplantation for breast cancer: Current status, future trends'
    Journal Article

    Seidman, A. D.
    Clinical Breast Cancer (2000)

    Fulltext@MSK | Save
  • Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer
    Journal Article

    Fornier, M.; Esteva, F. J.; Seidman, A. D.
    Seminars in Oncology (2000)

    Fulltext@MSK | Save
  • Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin
    Journal Article

    Baselga, J.; Pfister, D.; Cooper, M. R.; Cohen, R.; Burtness, B.; Bos, M.; D'Andrea, G.; Seidman, A.; Norton, L.; Gunnett, K.; more...
    Journal of Clinical Oncology (2000)

    Fulltext@MSK | Save
  • An immunotherapeutic approach to treatment of breast cancer: Focus on trastuzumab plus paclitaxel
    Journal Article

    Gilewski, T.; Seidman, A.; Norton, L.; Hudis, C.
    Cancer Chemotherapy and Pharmacology (2000)

    Fulltext@MSK | Save